McKune John
Known title: Interim CFOCIK: 0001650427
Associated companies
Transaction History
| LUNG | ▼ Sell | Open Market | 155 | $1K | 3/1/2024 | View on chart |
| LUNG | ▼ Sell | Open Market | 254 | $2K | 3/1/2024 | View on chart |
| LUNG | ▼ Sell | Open Market | 669 | $6K | 3/1/2024 | View on chart |
| LUNG | ▲ Buy | Grant | 14,400 | $0 | 3/1/2024 | View on chart |
| LUNG | ▼ Sell | Open Market | 135 | $1K | 12/1/2023 | View on chart |
| LUNG | ▼ Sell | Open Market | 222 | $2K | 12/1/2023 | View on chart |
| LUNG | ▼ Sell | Open Market | 585 | $6K | 12/1/2023 | View on chart |
| LUNG | ▲ Buy | Grant | 7,233 | $0 | 12/1/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Pulmonx Sets Q3 2026 Earnings Date for October 27
Pulmonx Corporation has announced that it will report its third-quarter 2026 financial results on October 27, 2026. This scheduled update provides a specific timeline for investors to review the company's latest performance metrics. The announcement serves as a standard corporate disclosure rather than a change in business operations.
Pulmonx Sets Q3 2026 Earnings Date for October 27. Pulmonx Corporation has announced that it will report its third-quarter 2026 financial results on October 27, 2026. This scheduled update provides a specific timeline for investors to review the company's latest performance metrics. The announcement serves as a standard corporate disclosure rather than a change in business operations.